# Merck Serono SA, Aubonne, Switzerland – FDA Inspections

Source: https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc

> Inspection records and compliance data for Merck Serono SA in Aubonne. 9 FDA inspections on record (1 OAI), 1 Form 483, last inspected November 25, 2025.

---

## Details

- Name: Merck Serono SA
- FEI Number: 3002807447
- Address Line 1: Zone Industrielle, De L'Ouriettaz
- City: Aubonne
- Country Name: Switzerland
- Address: Zone Industrielle, De L'Ouriettaz, Aubonne, Switzerland
- Country: Switzerland

## Related Documents

- FDA Inspection 1298388 - Merck Serono SA - 2025-11-25 — source: FDA, date: November 25, 2025
- FDA Inspection 1209187 - Merck Serono SA - 2023-05-02 — classification: No Action Indicated (NAI), source: FDA, date: May 2, 2023
- [483 - Merck Serono SA - 2022-07-08](https://www.keypedia.com/records/483/merck-serono-sa/736f1912-9818-4689-b96f-1747753f5240) — source: FDA, date: July 8, 2022
- FDA Inspection 1122463 - Merck Serono SA - 2020-02-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 18, 2020
- [FDA Inspection 1051545 - Merck Serono SA - 2018-05-09](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/9b6ada5e-805a-412e-b05b-6de574a13d76) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 9, 2018
- [FDA Inspection 947757 - Merck Serono SA - 2015-11-06](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/3f6397d7-2aad-4229-b733-773978761e61) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 6, 2015
- FDA Inspection 857686 - Merck Serono SA - 2013-11-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 12, 2013
- FDA Inspection 811249 - Merck Serono SA - 2012-11-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 16, 2012
- [FDA Inspection 732616 - Merck Serono SA - 2011-06-16](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/ec28250f-7ba3-4d9b-a5ef-00d359890f9f) — classification: Official Action Indicated (OAI), source: FDA, date: June 16, 2011
- FDA Inspection 649445 - Merck Serono SA - 2009-12-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 9, 2009

## Related Companies

- [Actavis Elizabeth LLC, A Company of Teva](https://www.keypedia.com/companies/actavis-elizabeth-llc-a-company-of-teva/c4a12fda-d6c3-4ad3-bac5-cc2b5695950e)
- [Shandong Anxin Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shandong-anxin-pharmaceutical-co-ltd/1bbdc465-0634-4e76-994f-a57ad864fc33)
- [Taro Pharmaceutical Industries, Ltd.](https://www.keypedia.com/companies/taro-pharmaceutical-industries-ltd/75bff305-a575-43eb-9c35-401fed5479be)
- [Boehringer Ingelheim Pharma Gmbh & Co Kg](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/5b2ffd33-30ee-4e73-bb66-fa96b4549154)
- [Reliance Life Sciences Private Limited](https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Jazz Pharmaceuticals Operations UK Limited](https://www.keypedia.com/companies/jazz-pharmaceuticals-operations-uk-limited/73701257-781b-43bb-a453-240dee8fae70)

## Related Officers

- [Zhong Li](https://www.keypedia.com/people/zhong-li/18545b20-7fa5-4850-9dd4-cffb40c41f8d)
- [Quality System Specialist](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)
